http://media.peerviewpress.com/000136/podcast/pvi/xml/rheumatology_audio.xml Thu, 07 Jan 2010 15:03:37 -0500 PeerView Rheumatology CME/CNE/CPE Audio Podcast PVI, PeerView Institute for Medical Education http://www.peerviewpress.com Podcast Maker v1.3.8b - http://www.lemonzdream.com/podcastmaker Thought leader perspectives on current clinical advances in medicine. PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. en-us 2007 PeerView Press, 24 West 40th STreet, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/rheumatology/podcast_RheumatologyCME-CNE-CPE_144.jpg PeerView Rheumatology CME/CNE/CPE Audio Podcast http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Rheumatology no Rene Westhovens, MD, PhD - Advances in Management of Early Rheumatoid Arthritis: Where Are We Now, and Where Are We Going? PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://podcast.peerviewpress.com/rheumatology/PPVNE06316s162.mp3 Thu, 07 Jan 2010 14:49:48 -0500 Science, Medicine no 00:24:30 arthritis, rheumatoid arthritis, RA, DMARDs, inflammatory synovitis CME/CNE/CPE - Advances in Management of Early Rheumatoid Arthritis: Where Are We Now, and Where Are We Going? PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/rheumatology/PPVNE06316CMEinfo.pdf Thu, 07 Jan 2010 14:49:46 -0500 Science, Medicine no 00:00:00 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Rheumatology Daniel J. Clauw, MD - Improving Patient Outcomes in Fibromyalgia Syndrome: A Clinical Update on Appropriate Diagnosis, Adequate Treatment, and Proper Management of Comorbid Conditions PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. This 3-part activity focuses on several aspects of the management of fibromyalgia. Highlights from the first part of the activity include the potential etiologies of fibromyalgia and tools to assist in the diagnosis of patients with this condition. The various types of pharmacologic and nonpharmacologic therapeutic approaches for fibromyalgia are discussed in the second part of the program. The third part of the activity addresses the treatment of comorbidity in patients with fibromyalgia. It also emphasizes the importance of an interdisciplinary approach for the management of fibromyalgia. http://podcast.peerviewpress.com/rheumatology/PPVNE06035r72.mp3 http://podcast.peerviewpress.com/rheumatology/PPVNE06035r72.mp3 Mon, 26 Oct 2009 15:19:52 -0400 Science, Medicine no 00:35:13 fibromyalgia; fibromyalgia syndrome; fibromyalgia treatment; fibromyalgia etiology CME/CNE/CPE - Improving Patient Outcomes in Fibromyalgia Syndrome: A Clinical Update on Appropriate Diagnosis, Adequate Treatment, and Proper Management of Comorbid Conditions PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/rheumatology/PPVNE06035CMEinfo.pdf http://podcast.peerviewpress.com/rheumatology/PPVNE06035CMEinfo.pdf Mon, 26 Oct 2009 15:19:49 -0400 Science, Medicine no 00:00:00 fibromyalgia; fibromyalgia syndrome; fibromyalgia treatment; fibromyalgia etiology Eric M. Ruderman, MD - Defining Clinical Practice in Early Rheumatoid Arthritis: An Expert Discussion PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts in RA discuss current evidence on optimal management of early RA, including the use of biologic agents. http://podcast.peerviewpress.com/rheumatology/PPVNE05984e23.mp3 http://podcast.peerviewpress.com/rheumatology/PPVNE05984e23.mp3 Wed, 09 Sep 2009 15:26:24 -0400 Science, Medicine no 00:19:43 rheumatoid arthritis, RA, biologic therapy CME/CNE/CPE - Defining Clinical Practice in Early Rheumatoid Arthritis: An Expert Discussion PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/rheumatology/PPVNE05984CMEinfo.pdf http://podcast.peerviewpress.com/rheumatology/PPVNE05984CMEinfo.pdf Wed, 09 Sep 2009 15:26:21 -0400 Science, Medicine no 00:00:00 rheumatoid arthritis, RA, biologic therapy Paul Emery, MA, MD - Benefits of Early, Aggressive, and Appropriate Intervention in Rheumatoid Arthritis PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts in management of rheumatoid arthritis discuss the importance of early, aggressive management of rheumatoid arthritis. http://podcast.peerviewpress.com/rheumatology/PA05128FCe026.mp3 http://podcast.peerviewpress.com/rheumatology/PA05128FCe026.mp3 Wed, 08 Apr 2009 14:33:35 -0400 Science, Medicine no 00:43:35 arthritis; rheumatoid arthritis; rheumatology; RA; RA treatment CME/CNE/CPE Information - Benefits of Early, Aggressive, and Appropriate Intervention in Rheumatoid Arthritis PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/rheumatology/PA05128FCCMEinfo.pdf http://podcast.peerviewpress.com/rheumatology/PA05128FCCMEinfo.pdf Wed, 08 Apr 2009 14:33:33 -0400 Science, Medicine no 00:00:00 arthritis; rheumatoid arthritis; rheumatology; RA; RA treatment Joel M. Kremer, MD - Current Perspectives and Latest Data in Undifferentiated Inflammatory & Rheumatoid Arthritis PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts in rheumatology discuss the latest data on treatment of RA, including the emerging evidence supporting early use of traditional and biologic antirheumatic drugs in undifferentiated arthritis and early stage RA, as well as up-to-date findings regarding the efficacy and safety of T- and B-cell-targeted biologics in RA. http://podcast.peerviewpress.com/rheumatology/PA05362FCr428.mp3 http://podcast.peerviewpress.com/rheumatology/PA05362FCr428.mp3 Thu, 19 Mar 2009 13:52:30 -0400 Science no 00:29:34 rheumatoid arthritis, undifferentiated, inflammatory, DMARDs, CCP, abatacept, etanercept, methotrexate, TNF, rituximab CME/CNE/CPE - Current Perspectives and Latest Data in Undifferentiated Inflammatory & Rheumatoid Arthritis PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/rheumatology/PA05362FCCMEinfo.pdf http://podcast.peerviewpress.com/rheumatology/PA05362FCCMEinfo.pdf Thu, 19 Mar 2009 13:52:27 -0400 Science no 00:00:00 rheumatoid arthritis, undifferentiated, inflammatory, DMARDs, CCP, abatacept, etanercept, methotrexate, TNF, rituximab Gregg J. Silverman, MD - The State of the Science in Managing Systemic Lupus Erythematosus: Update From EULAR 2008 PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts on SLE review current and emerging treatments, discuss the latest treatment guidelines from EULAR, and propose therapeutic strategies for patients with lupus nephritis. http://podcast.peerviewpress.com/rheumatology/PA04880FCr405.mp3 http://podcast.peerviewpress.com/Rheumatology/PA04880FCr405.mp3 Wed, 27 Aug 2008 16:26:27 -0400 Science no 00:27:46 lupus nephritis, antimalarials, glucocorticoids, NSAIDs, immunosuppressive agents, belimumab, epratuzumab, infliximab, mycophenolate mofetil, rituximab, cyclophosphamide, EXPLORER CME/CE Information - The State of the Science in Managing Systemic Lupus Erythematosus: Update From EULAR 2008 PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/rheumatology/PA04880FCCMEinfo.pdf http://podcast.peerviewpress.com/Rheumatology/PA04880FCCMEinfo.pdf Wed, 27 Aug 2008 16:26:26 -0400 Science no 00:00:00 lupus nephritis, antimalarials, glucocorticoids, NSAIDs, immunosuppressive agents, belimumab, epratuzumab, infliximab, mycophenolate mofetil, rituximab, cyclophosphamide, EXPLORER Philip Mease, MD - Beyond Efficacy and Safety in Rheumatoid Arthritis Treatment: Quality-of-Life Outcomes With Newer Biologics in RA PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of rheumatoid arthritis evaluate recent data on the impact of newer biologics on functional outcomes and quality-of-life parameters. A review of the efficacy and safety of these agents is featured. http://podcast.peerviewpress.com/rheumatology/PA03791FC3r363.mp3 http://podcast.peerviewpress.com/Rheumatology/PA03791FC3r363.mp3 Thu, 10 Apr 2008 15:50:55 -0400 Science no 00:29:19 Rheumatoid arthritis, ACR, AIM, ATTAIN, abatacept, anti-TNF, DANCER, HAQ, mHAQ, MDHAQ, REFLEX, rituximab CME/CE Information Beyond Efficacy and Safety in Rheumatoid Arthritis Treatment: Quality-of-Life Outcomes With Newer Biologics in RA PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/rheumatology/PA03791FC3CMEinfo.pdf http://podcast.peerviewpress.com/Rheumatology/PA03791FC3CMEinfo.pdf Thu, 10 Apr 2008 15:50:53 -0400 Science no 00:00:00 Rheumatoid arthritis, ACR, AIM, ATTAIN, abatacept, anti-TNF, DANCER, HAQ, mHAQ, MDHAQ, REFLEX, rituximab Felicia Cosman, MD - Updates in the Diagnosis and Management of Osteoporosis: A Rheumatology Perspective PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, an expert in the management of osteoporosis discusses optimal diagnostic approaches and recent data on strategies to manage this condition. The role of the rheumatologist in the management of osteoporosis is also reviewed. http://podcast.peerviewpress.com/rheumatology/PA04073FCn173.mp3 http://podcast.peerviewpress.com/Rheumatology/PA04073FCn173.mp3 Thu, 20 Mar 2008 16:32:20 -0400 Science no 00:29:30 Bisphosphonates, BMD, calcium, fracture, osteoporosis, raloxifene, rheumatic disease, tamoxifen, SERMs, teriparatide, vitamin D CME/CE Information - Updates in the Diagnosis and Management of Osteoporosis: A Rheumatology Perspective PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/rheumatology/PA04073FCCMEinfo.pdf http://podcast.peerviewpress.com/Rheumatology/PA04073FCCMEinfo.pdf Thu, 20 Mar 2008 16:32:17 -0400 Science no 00:00:00 Bisphosphonates, BMD, calcium, fracture, osteoporosis, raloxifene, rheumatic disease, tamoxifen, SERMs, teriparatide, vitamin D Joel M. Kremer, MD - Safety Update of Newer Biologics in Refractory Rheumatoid Arthritis PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of rheumatoid arthritis (RA) discuss updated safety data associated with the use of abatacept or rituximab in methotrexate- or TNF-antagonist-refractory RA. http://podcast.peerviewpress.com/rheumatology/PA03791FC2r362.mp3 http://podcast.peerviewpress.com/Rheumatology/PA03791FC2r362.mp3 Wed, 27 Feb 2008 16:39:45 -0500 Science no 00:33:20 Rheumatoid, arthritis, biologics, safety, abatacept, rituximab, DMARDs, TNF, antagonists, AIM, SERENE, IMAGE, SUNRISE, DANCER, infusion, reactions CME/CE Information - Safety Update of Newer Biologics in Refractory Rheumatoid Arthritis PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/rheumatology/PA03791FCCMEinfo.pdf http://podcast.peerviewpress.com/Rheumatology/PA03791FCCMEinfo_2.pdf Wed, 27 Feb 2008 16:39:41 -0500 Science no 00:00:00 Rheumatoid, arthritis, biologics, safety, abatacept, rituximab, DMARDs, TNF, antagonists, AIM, SERENE, IMAGE, SUNRISE, DANCER, infusion, reactions Paul Emery, MD, FRCP - Long-Term Efficacy of Newer Biologics in Refractory Rheumatoid Arthritis PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of rheumatoid arthritis discuss recent data on the use of abatacept and rituximab in methotrexate- or TNF-antagonist-refractory rheumatoid arthritis. http://podcast.peerviewpress.com/rheumatology/PA03791FCr361.mp3 http://podcast.peerviewpress.com/Rheumatology/PA03791FCr361.mp3 Wed, 13 Feb 2008 16:08:44 -0500 Science no 00:25:12 Rheumatoid arthritis, abatacept, rituximab, DANCER, REFLEX, AIM, ATTAIN, ACR, EULAR, radiographic CME/CE Information - Long-Term Efficacy of Newer Biologics in Refractory Rheumatoid Arthritis PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/rheumatology/PA03791FCCMEinfo.pdf http://podcast.peerviewpress.com/Rheumatology/PA03791FCCMEinfo.pdf Wed, 13 Feb 2008 16:08:40 -0500 Science no 00:00:00 Rheumatoid arthritis, abatacept, rituximab, DANCER, REFLEX, AIM, ATTAIN, ACR, EULAR, radiographic Mark Genovese, MD - Clinical Update on Biologic Treatment Options for Rheumatoid Arthritis PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, experts provide an update on the latest data on efficacy and safety of current and novel biologic therapies for rheumatoid arthritis (RA). Additionally, the activity will provide information from new RA treatment guidelines intended to help physicians understand when to start nonbiologic and biologic therapies in RA. http://podcast.peerviewpress.com/rheumatology/PA03799FCs441.mp3 http://podcast.peerviewpress.com/Rheumatology/PA03799FCs441.mp3 Fri, 18 Jan 2008 16:40:36 -0500 Science no 00:27:17 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Rheumatology CME/CE Information - Clinical Update on Biologic Treatment Options for Rheumatoid Arthritis PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/rheumatology/PA03799FCCMEinfo.pdf http://podcast.peerviewpress.com/Rheumatology/PA03799FCCMEinfo.pdf Fri, 18 Jan 2008 16:40:33 -0500 Science no 00:00:00 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Rheumatology Daniel J. Clauw, MD - Understanding and Managing the Fibromyalgia Syndrome PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, experts in the treatment of fibromyalgia present recent data on its diagnosis and management. Recent research on causes, mechanisms, and genetic markers are also highlighted. http://podcast.peerviewpress.com/rheumatology/PA04159FCr353.mp3 http://podcast.peerviewpress.com/Rheumatology/PA04159FCr353.mp3 Wed, 16 Jan 2008 17:36:28 -0500 Science no 00:28:06 Fibromyalgia, FMS, myofascial pain syndrome, chronic fatigue syndrome, hypothyroidism, depression, posttraumatic stress disorder, ACR criteria, genetic factors, central sensitization, pregabalin, duloxetine, milnacipran, tricyclic antidepressants CME/CE Information - Understanding and Managing the Fibromyalgia Syndrome PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/rheumatology/PA04159FCCMEinfo.pdf http://podcast.peerviewpress.com/Rheumatology/PA04159FCCMEinfo.pdf Wed, 16 Jan 2008 17:36:25 -0500 Science no 00:00:00 Fibromyalgia, FMS, myofascial pain syndrome, chronic fatigue syndrome, hypothyroidism, depression, posttraumatic stress disorder, ACR criteria, genetic factors, central sensitization, pregabalin, duloxetine, milnacipran, tricyclic antidepressants Michael Schiff, MD - Expanding the Options in RA: Where Do the Newer Biologics Fit? PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of rheumatoid arthritis review recent data on the safety and efficacy of newer biologics for the treatment of patients with this condition. http://podcast.peerviewpress.com/rheumatology/PA03526FC3r329.mp3 http://podcast.peerviewpress.com/Rheumatology/PA03526FC3r329.mp3 Tue, 13 Nov 2007 09:55:04 -0500 Science no 00:38:55 Rheumatoid arthritis, RA, EULAR 2007, ACR 2006, abatacept, rituximab, TNF, anti-TNF, non-responder, methotrexate, etanercept, adalimumab, infliximab CME/CE Information - Expanding the Options in RA: Where Do the Newer Biologics Fit? PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/rheumatology/PA03526FCCMEinfo.pdf http://podcast.peerviewpress.com/Rheumatology/PA03526FCCMEinfo.pdf Tue, 13 Nov 2007 09:55:00 -0500 Science no 00:00:00 Rheumatoid arthritis, RA, EULAR 2007, ACR 2006, abatacept, rituximab, TNF, anti-TNF, non-responder, methotrexate, etanercept, adalimumab, infliximab Stanley B. Cohen, MD - Challenges in Managing Rheumatoid Arthritis With Biologics: A Case-Based Approach PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, an expert discusses treatment of rheumatoid arthritis based on relevant case scenarios, with a main focus on optimal use of biologic therapies in the context of other available treatment options. http://podcast.peerviewpress.com/rheumatology/PA03770FCp124.mp3 http://podcast.peerviewpress.com/Rheumatology/PA03770FCp124.mp3 Tue, 06 Nov 2007 16:06:51 -0500 Science no 00:37:23 Rheumatology, rheumatoid arthritis, DMARDs, TNF inhibitors, B-cell targeted therapy, rituximab, abatacept CME/CE Information - Challenges in Managing Rheumatoid Arthritis With Biologics: A Case-Based Approach PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/rheumatology/PA03770FCCMEinfo.pdf http://podcast.peerviewpress.com/Rheumatology/PA03770FCCMEinfo.pdf Tue, 06 Nov 2007 16:06:48 -0500 Science no 00:00:00 Rheumatology, rheumatoid arthritis, DMARDs, TNF inhibitors, B-cell targeted therapy, rituximab, abatacept